Questions: Vitamin D: Synthesis, Metabolism, and Endocrine Functions

Question 1

A patient with end-stage chronic kidney disease develops bone pain, muscle weakness, and low serum calcium despite living in a sunny climate and eating fatty fish twice weekly. Their serum 25(OH)D is normal. What is the most likely explanation?

• A. Melanin in their skin is blocking UV-B synthesis of vitamin D₃
• B. The liver is failing to perform the first hydroxylation step
• C. The kidneys cannot convert 25(OH)D to the active 1,25-dihydroxyvitamin D
• D. The vitamin D receptor in target tissues is unresponsive to calcitriol

Answer: (C)

Normal 25(OH)D confirms that skin synthesis and hepatic 25-hydroxylation are intact — the problem is the second activation step. The kidney's 1α-hydroxylase converts the storage form (calcidiol) to the active hormone (calcitriol). In chronic kidney disease, this enzyme activity is lost, so even with adequate vitamin D supply from sun and diet, the body cannot produce functional calcitriol. This is why patients with renal failure commonly develop renal osteodystrophy and require supplementation with the active form (calcitriol or alfacalcidol) rather than ordinary vitamin D.

Question 2

Which form of vitamin D is measured in serum to assess a patient's overall vitamin D status, and why is this the appropriate clinical marker?

• A. 7-dehydrocholesterol, because it reflects the skin's synthetic capacity
• B. Vitamin D₃ (cholecalciferol), because it is the form produced by UV-B exposure
• C. 25-hydroxyvitamin D (calcidiol), because hepatic hydroxylation is largely unregulated and reflects total vitamin D from all sources
• D. 1,25-dihydroxyvitamin D (calcitriol), because it is the biologically active hormone

Answer: (C)

25(OH)D (calcidiol) is the correct clinical marker because the hepatic 25-hydroxylation step is constitutive and largely unregulated — it simply converts whatever vitamin D is available (from skin synthesis or diet) into the circulating storage form. This makes serum 25(OH)D an integrative measure of total vitamin D status from all sources. Calcitriol is a poor marker despite being the active form, because its production is tightly regulated by PTH, phosphate, and feedback — it stays near-normal until vitamin D status is severely depleted, masking deficiency.

Question 3

The active form of vitamin D, calcitriol, functions by binding a nuclear receptor that heterodimerizes with RXR and regulates gene transcription in target cells — a mechanism identical to other steroid hormones.

• T. True
• F. False

Answer: True

This is correct and reflects why vitamin D is classified as a steroid hormone rather than a classical vitamin. Calcitriol diffuses into target cells, binds the vitamin D receptor (VDR) — a nuclear receptor — and the VDR-calcitriol complex pairs with the retinoid X receptor (RXR) to form a heterodimer that binds vitamin D response elements (VDREs) in DNA, activating or repressing gene transcription. This is the canonical steroid hormone signaling pathway, distinct from the membrane receptor and second messenger cascades used by peptide hormones.

Question 4

Dietary vitamin D₃ from a supplement is biologically active and can directly increase intestinal calcium absorption without requiring metabolic conversion.

• T. True
• F. False

Answer: False

Dietary or supplemental vitamin D₃ (cholecalciferol) is biologically inert until it undergoes two sequential hydroxylation reactions. First, the liver adds a hydroxyl group at carbon-25 to produce calcidiol (the storage form). Then the kidney adds a hydroxyl group at carbon-1α to produce calcitriol (the active hormone). Only calcitriol can bind the VDR and upregulate calcium transport proteins (TRPV6, calbindin-D9k) in intestinal cells to increase calcium absorption. Bypassing these activation steps — as with direct calcitriol supplementation in renal failure — is precisely why the distinction matters clinically.

Question 5

Explain why vitamin D is more accurately classified as a hormone than a vitamin, and describe what regulates the final activation step.

Model answer: Vitamin D is a hormone because its active form (calcitriol) is synthesized in one tissue (the kidney), released into circulation, and acts on distant target tissues via nuclear receptors to regulate gene expression — the definition of a steroid hormone. Unlike true vitamins, the body can synthesize adequate amounts from sunlight without any dietary source. The final activation step — 1α-hydroxylation in the kidney — is tightly regulated: PTH and low serum phosphate upregulate the enzyme when calcium-phosphorus status is low; calcitriol itself and FGF-23 downregulate it when levels are adequate. This feedback loop is characteristic of hormonal systems, not nutrient metabolism.

The hormone classification matters practically: it explains why measuring and supplementing vitamin D is more complex than other vitamins, why kidney disease specifically causes vitamin D deficiency despite adequate sun exposure, and why vitamin D insufficiency has wide-ranging effects beyond bone (immune regulation, cardiovascular function) — because VDR is expressed in tissues throughout the body. The tightly regulated final activation step is the body's way of controlling active hormone output based on real-time calcium and phosphorus needs.